Who owns Scpharmaceuticals Inc?
- Ticker: SCPH
- CUSIP Number: 810648105
Tip: Access positions for across all investors
Analyze quarterly positions in Scpharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Scpharmaceuticals stock
Who bought or sold Scpharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 5.6M | $28M | 0% | Mar 2024 |
|
| Rubric Capital Management | 3.5M | $18M | 30% | Mar 2024 |
|
| AIGH Capital Management | 3.4M | $17M | 9% | Mar 2024 |
|
| BlackRock | 1.8M | $9.0M | 4% | Mar 2024 |
|
| Luther King Capital Management Corporation | 1.4M | $8.7M | 49% | Dec 2023 |
|
| Vanguard Group | 1.4M | $6.9M | 0% | Mar 2024 |
|
| 5AM Venture Management | 1.2M | $6.0M | 0% | Mar 2024 |
|
| J. Goldman & Co | 1.1M | $5.6M | -20% | Mar 2024 |
|
| Thrivent Financial for Lutherans | 1.1M | $5.4M | 2% | Mar 2024 |
|
| Tejara Capital | 698k | $3.5M | -8% | Mar 2024 |
|
| Citadel Advisors | 616k | $3.1M | 210% | Mar 2024 |
|
| Walleye Trading Advisors | 556k | $2.8M | -34% | Mar 2024 |
|
| Geode Capital Management | 542k | $2.7M | 6% | Mar 2024 |
|
| Rice Hall James & Associates | 281k | $1.4M | 247% | Mar 2024 |
|
| Northern Trust | 265k | $1.3M | -2% | Mar 2024 |
|
| Kennedy Capital Management | 220k | $1.1M | -1% | Mar 2024 |
|
| Millennium Management | 189k | $949k | -47% | Mar 2024 |
|
| Bridgeway Capital Management | 189k | $949k | 31% | Mar 2024 |
|
| Morgan Stanley | 181k | $907k | -84% | Mar 2024 |
|
| Dimensional Fund Advisors | 166k | $834k | -4% | Mar 2024 |
|
| Nuveen Asset Management | 91k | $454k | 0% | Mar 2024 |
|
| Ameriprise Financial | 86k | $431k | -15% | Mar 2024 |
|
| Raymond James & Associates | 85k | $427k | -2% | Mar 2024 |
|
| Bank of New York Mellon | 75k | $376k | -8% | Mar 2024 |
|
| Charles Schwab Investment Management | 73k | $364k | -6% | Mar 2024 |
|
| Squarepoint Ops | 62k | $313k | 24% | Mar 2024 |
|
| Caption Management | 58k | $290k | 0% | Mar 2024 |
|
| Balanced Rock Investment Advisors | 57k | $287k | 100% | Mar 2024 |
|
| Susquehanna International | 53k | $266k | -32% | Mar 2024 |
|
| TNB Financial | 37k | $185k | 12% | Mar 2024 |
|
| Rhumbline Advisers | 36k | $183k | 2% | Mar 2024 |
|
| Jane Street | 36k | $178k | 48% | Mar 2024 |
|
| UBS Group | 34k | $172k | 16% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 33k | $163k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 31k | $158k | 0% | Mar 2024 |
|
| Goldman Sachs Group | 28k | $142k | -37% | Mar 2024 |
|
| Bank of America Corporation | 28k | $142k | -13% | Mar 2024 |
|
| Mitsubishi UFJ Asset Management | 21k | $104k | -21% | Mar 2024 |
|
| Barclays | 20k | $102k | -49% | Mar 2024 |
|
| Assenagon Asset Management | 20k | $100k | 100% | Mar 2024 |
|
| Virtu Financial | 18k | $90k | 100% | Mar 2024 |
|
| MetLife Investment Advisors | 15k | $96k | 0% | Dec 2023 |
|
| Sherbrooke Park Advisers | 14k | $72k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 14k | $72k | 1% | Mar 2024 |
|
| American International | 14k | $90k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 14k | $72k | 807% | Mar 2024 |
|
| Captrust Financial Advisors | 14k | $71k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 12k | $60k | -39% | Mar 2024 |
|
| IPG Investment Advisors | 12k | $75k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 12k | $58k | 0% | Mar 2024 |
|
| Tower Research Capital | 11k | $54k | -11% | Mar 2024 |
|
| Perkins Capital Management | 11k | $53k | 100% | Mar 2024 |
|
| Sandy Cove Advisors | 11k | $53k | 0% | Mar 2024 |
|
| Alliancebernstein | 10k | $65k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 8.6k | $43k | 16% | Mar 2024 |
|
| Advisor Group Holdings | 5.6k | $28k | 6% | Mar 2024 |
|
| Citigroup | 4.8k | $24k | 15% | Mar 2024 |
|
| Legal & General Group | 3.0k | $15k | 0% | Mar 2024 |
|
| FMR | 3.0k | $15k | 294% | Mar 2024 |
|
| California State Teachers Retirement System | 2.9k | $15k | -54% | Mar 2024 |
|
| Summit Investment Advisors | 2.4k | $12k | 0% | Mar 2024 |
|
| Worth Venture Partners | 2.3k | $12k | -100% | Mar 2024 |
|
| Royal Bank of Canada | 1.7k | $8.3k | -83% | Mar 2024 |
|
| Amalgamated Bank | 973.00 | $5.0k | -76% | Mar 2024 |
|
| GAMMA Investing | 833.00 | $4.2k | 3% | Mar 2024 |
|
| Nordwand Advisors | 500.00 | $2.5k | 100% | Mar 2024 |
|
| Atlantic Edge Private Wealth Management | 425.00 | $2.1k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 369.00 | $2.3k | -77% | Dec 2023 |
|
| Farther Finance Advisors | 59.00 | $286.002500 | 100% | Mar 2024 |
|
| Pnc Financial Services | 28.00 | $140.999600 | 180% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 6.00 | $30.000000 | 100% | Mar 2024 |
|
Who sold out of Scpharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| American Century Companies | Sep 2023 | 841k | $6.0M |
| Leucadia National Corporation | Dec 2023 | 500k | $3.1M |
| AlphaCentric Advisors | Sep 2023 | 125k | $890k |
| Alberta Investment Management Corporation | Sep 2023 | 111k | $793k |
| Manatuck Hill Partners | Dec 2023 | 91k | $572k |
| Laurion Capital Management | Dec 2023 | 42k | $263k |
| Marshall Wace | Dec 2023 | 34k | $216k |
| Walleye Trading | Dec 2023 | 33k | $205k |
| Wolverine Trading | Dec 2023 | 20k | $124k |
| Mirae Asset Global Investments | Dec 2023 | 15k | $93k |
| Two Sigma Investments | Dec 2023 | 13k | $80k |
| Concurrent Investment Advisors | Dec 2023 | 13k | $78k |
| Ing Investment Management | Sep 2023 | 12k | $84k |
| AQR Capital Management | Dec 2023 | 10k | $64k |
| Simplex Trading | Dec 2023 | 3.3k | $20k |
| Group One Trading | Sep 2023 | 2.1k | $15k |
| TD Waterhouse Canada | Dec 2023 | 150.00 | $1.3k |